Evaluation of epicardial fat tissue thickness in patients with hyperthyroidism

Basit Öğe Kaydı
dc.authoridAsik, mehmet/0000-0002-0716-0221
dc.contributor.authorBinnetoglu, Emine
dc.contributor.authorAsik, Mehmet
dc.contributor.authorAltun, Burak
dc.contributor.authorSen, Hacer
dc.contributor.authorGazi, Emine
dc.contributor.authorErbag, Gokhan
dc.contributor.authorGunes, Fahri
dc.date.accessioned2025-01-27T20:39:19Z
dc.date.available2025-01-27T20:39:19Z
dc.date.issued2014
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractThyroid hormones have several effects on the cardiovascular system, and recent studies have found that thyroid disorders affect coronary intima-media thickness (CIMT) in particular. Despite increased CIMT in patients with hyperthyroidism, the extent of the relationship between CIMT and epicardial fat thickness (EFT) in those patients is unknown. Furthermore, there is no report evaluating the relationship between EFT and overt hyperthyroidism (OH) in the literature. In this study, we aim to evaluate the effectiveness of EFT in predicting atherosclerosis as well as CIMT in patients with OH. A total of 30 newly diagnosed, untreated overt hyperthyroid patients and 44 control subjects were included in the study. EFT was measured using a commercially available echocardiography machine (VIVID 7; General Electric Medical Systems, Norway) with a 2.5-MHz probe. The echo-free space between the visceral and parietal pericardium on the anterior wall of the right ventricle was diagnosed as EFT. A linear-array imaging probe of the same echocardiography probe was used to evaluate the CIMT of the right common carotid artery. The hyperthyroid patients had a significantly greater EFT (mean: 4.31 +/- A 1.12 mm) than the healthy subjects (mean: 3.11 +/- A 0.84 mm; p < 0.001). CIMT was also significantly greater in the hyperthyroid patients (mean: 0.62 +/- A 0.17 mm) than in the healthy subjects (mean: 0.50 +/- A 0.11 mm; p < 0.01). In conclusion, the present study shows that mean EFT and CIMT were significantly higher in OH patients, irrespective of confounding factors such as hypertension.
dc.identifier.doi10.1007/s00508-014-0570-0
dc.identifier.endpage490
dc.identifier.issn0043-5325
dc.identifier.issn1613-7671
dc.identifier.issue15-16
dc.identifier.pmid25135746
dc.identifier.scopus2-s2.0-84906936104
dc.identifier.scopusqualityQ1
dc.identifier.startpage485
dc.identifier.urihttps://doi.org/10.1007/s00508-014-0570-0
dc.identifier.urihttps://hdl.handle.net/20.500.12428/23922
dc.identifier.volume126
dc.identifier.wosWOS:000341425800007
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer Wien
dc.relation.ispartofWiener Klinische Wochenschrift
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectAtherosclerosis
dc.subjectEpicardial fat tissue thickness
dc.subjectHyperthyroidism
dc.titleEvaluation of epicardial fat tissue thickness in patients with hyperthyroidism
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu